Deutsche Bank Initiates Coverage on On Assignment(NYSE:ASGN). The shares have been rated Buy. The rating by Deutsche Bank was issued on Aug 18, 2016.
On Assignment (ASGN) shares turned negative on Mondays trading session with the shares closing down -0.13 points or -0.34% at a volume of 1,56,313. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $38.25. The peak price level was also seen at $38.25 while the days lowest was $37.76. Finally the shares closed at $37.86. The 52-week high of the shares is $51 while the 52-week low is $29.34. According to the latest information available, the market cap of the company is $2,020 M.
On Assignment(ASGN) last announced its earnings results on Jul 27, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $608.09M. Analysts had an estimated revenue of $600.03M. Earnings per share were $0.80. Analysts had estimated an EPS of $0.78.
Several Insider Transactions has been reported to the SEC. On Jun 15, 2016, Michael Mcgowan (COO, OAI; Pres, OGR) sold 8,000 shares at $37.01 per share price.Also, On Apr 19, 2016, Peter T Dameris (President & CEO) sold 140,000 shares at $46.89 per share price.On Dec 11, 2015, William E Brock (director) sold 6,523 shares at $45.88 per share price, according to the Form-4 filing with the securities and exchange commission.
On Assignment Inc. is a global provider of professionals in the information technology (IT) engineering and life sciences sectors. The Company matches people into positions for contract contract-to-hire and direct hire assignments. Its operating segments include Apex Oxford and Life Sciences Europe. The Apex Segment provides information technology and scientific staffing professionals for contract contract-to-hire and permanent placement positions. The Oxford Segment provides contract and direct placement services of information technology and engineering professionals in specialized information technology software and hardware engineering and mechanical electrical validation and telecommunications engineering fields. The Life Sciences Europe Segment provides locally-based contract life science professionals to clients in the biotechnology pharmaceutical food and beverage medical device personal care chemical automotive educational and environmental industries.